Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and sazetidine-a

quinoxalines has been researched along with sazetidine-a in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blendy, JA; Castellano, LM; Turner, JR1
Caldarone, B; Ghavami, A; Hackett, A; Hanania, T; Lowe, D; Min, W; Paterson, NE1
Caldarone, BJ; Cavino, K; Chellappan, SK; Fedolak, A; Ghavami, A; Hanania, T; Kozikowski, AP; Kwan, M; Manzano, M; Olivier, B; Paterson, NE; Picciotto, MR; Wang, D1
AlSharari, SD; Carroll, FI; Damaj, MI; McIntosh, JM1
Blendy, JA; Cousins, V; Hussmann, GP; Kellar, KJ; Levin, ED; Lomazzo, E; Perry, DC; Rezvani, AH; Turner, JR; Venkatesh, R; Wolfe, BB; Xiao, Y; Yasuda, RP1
Blendy, JA; Carlson, GC; Gould, TJ; Poole, RL; Turner, JR; Wilkinson, DS1
Blendy, JA; DeDominicis, KE; Forcelli, PA; Hussmann, GP; Kellar, KJ; Klehm, J; Lindstrom, J; Richardson, JR; Sahibzada, N; Turner, JR; Wolfe, BB; Xiao, Y; Yasuda, RP1
Cameron, P; Crooks, PA; Dwoskin, LP; Holt, JC; Jordan, PM; Kewin, K; Klapczynski, M; Lysakowski, A; McIntosh, JM1

Other Studies

8 other study(ies) available for quinoxalines and sazetidine-a

ArticleYear
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 334, Issue:2

    Topics: Animals; Anxiety; Azetidines; Behavior, Animal; Benzazepines; Chimera; Depression; Drug Partial Agonism; Male; Mice; Mood Disorders; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Varenicline

2010
The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2010, Dec-01, Volume: 34, Issue:8

    Topics: Animals; Azetidines; Benzazepines; Discrimination Learning; Drug Partial Agonism; Male; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Varenicline

2010
Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.
    Psychopharmacology, 2011, Volume: 217, Issue:2

    Topics: Animals; Antidepressive Agents; Azetidines; Behavior, Animal; Benzazepines; Brain; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Ligands; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Motor Activity; Nicotinic Agonists; Protein Binding; Pyridines; Quinoxalines; Receptors, Nicotinic; Swimming; Time Factors; Varenicline

2011
The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:3

    Topics: Analgesics; Animals; Azetidines; Benzazepines; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Motor Activity; Nicotinic Agonists; Pain; Pain Measurement; Pyridines; Quinoxalines; Receptors, Nicotinic; Varenicline

2012
Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 343, Issue:2

    Topics: Animals; Azetidines; Behavior, Animal; Benzazepines; Binding Sites; Brain Chemistry; Cerebral Cortex; Dose-Response Relationship, Drug; Female; Male; Membranes; Neurons; Nicotine; Nicotinic Agonists; Pregnancy; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Up-Regulation; Varenicline

2012
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:10

    Topics: Animals; Anxiety; Azetidines; Benzazepines; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Partial Agonism; Evoked Potentials; Hippocampus; Male; Mice; Microinjections; Motor Activity; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Up-Regulation; Varenicline

2013
Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
    Journal of neurochemistry, 2014, Volume: 129, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Azetidines; Benzazepines; Brain Chemistry; Drug Evaluation, Preclinical; Feeding Behavior; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Up-Regulation; Varenicline; Weight Gain

2014
Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, Feb-25, Volume: 35, Issue:8

    Topics: Animals; Azetidines; Benzazepines; Bungarotoxins; Cholinergic Agonists; Cholinergic Antagonists; Conotoxins; Female; Male; Motor Neurons; Picolines; Presynaptic Terminals; Protein Subunits; Pyridines; Quinoxalines; Receptors, Cholinergic; Turtles; Varenicline; Vestibular Nerve

2015